Cofactor Genomics

OverviewSuggest Edit

Cofactor Genomics is a company that uses RNA to diagnose disease. It offers ImmunoPrism Assay, a solution with validated reagents and cloud-based informatics.

TypePrivate
Founded2008
HQSan Francisco, CA, US
Websitecofactorgenomics.com
Employee Ratings4.7
Overall CultureB+

Latest Updates

Employees (est.) (Jun 2021)18
Cybersecurity ratingBMore

Key People/Management at Cofactor Genomics

Jarret Glasscock

Jarret Glasscock

Founder and CEO
Eric Duncavage

Eric Duncavage

Medical Director
Jon Armstrong

Jon Armstrong

CSO
Dave Messina

Dave Messina

COO
Natalie Lafranzo

Natalie Lafranzo

Vice President, Market Development
Show more

Cofactor Genomics Office Locations

Cofactor Genomics has offices in San Francisco and St. Louis
San Francisco, CA, US (HQ)
600 California St, San Francisco
St. Louis, MO, US
4044 Clayton Ave
Show all (2)

Cofactor Genomics Financials and Metrics

Summary Metrics

Founding Date

2008

Cofactor Genomics total Funding

$20.9 m

Cofactor Genomics latest funding size

$18 m

Time since last funding

4 years ago

Cofactor Genomics investors

Cofactor Genomics's latest funding round in September 2017 was reported to be $18 m. In total, Cofactor Genomics has raised $20.9 m
Show all financial metrics

Cofactor Genomics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Cofactor Genomics Online and Social Media Presence

Embed Graph

Cofactor Genomics Company Culture

  • Overall Culture

    B+

    85/100

  • CEO Rating

    A+

    85/100

  • Compensation

    D+

    61/100

Learn more on Comparably

Cofactor Genomics Blogs

Cofactor Genomics Commences First Predictive Immune Modeling Clinical Trial to Bridge Precision Medicine Gap for Immunotherapy

SAN FRANCISCO, Calif. – April 13, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its OncoPrismTM diagnostic assay, using the company’s patented approach to generating multidimensional immune biomarker…

New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer

PROVIDENCE, R.I. – March 8, 2021 (Reportable News)– Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology by Women & Infants Hospital of Rhode Island. The data highlight the utility of Cofactor’s Predictive Immune Modeling…

Are predictive diagnostics the Doppler radar of disease?

February 2, 2021 (Drug Discovery & Development) What do cupcakes and Doppler radar have to do with oncology, and more specifically, predictive diagnostics? Before I explain, I’ll provide some context. I recently came across an image that illustrated the difference between how Doppler radar detec…

Why the Future of Diagnostics Requires a New Approach to Trials

December 15, 2020 (Clinical Researcher) Scientific and medical research is an investment in our future. We’re all keen to live long, healthy lives and most of us are willing to empower physicians to make educated decisions about our care if and when we do become ill. Further, as we’ve seen from hund…

5 Best HealthTech Solution Providers to Watch 2020

November 10, 2020 (The Silicon Review) Cofactor Genomics is shortlisted in The Silicon Review’s 5 Best HealthTech Solution Providers to watch in 2020. See the listing and read more about Cofactor’s breakthrough technology. Read more…

How to close the precision medicine gap

October 19, 2020 (BioTechniques) Matching cancer patients to the therapies that provide the best chance of overcoming their disease is a difficult process, leading to a gap between the wealth of groundbreaking treatments available and improvements in clinical outcomes. But could there be a solution …
Show more

Cofactor Genomics Frequently Asked Questions

  • When was Cofactor Genomics founded?

    Cofactor Genomics was founded in 2008.

  • Who are Cofactor Genomics key executives?

    Cofactor Genomics's key executives are Jarret Glasscock, Eric Duncavage and Jon Armstrong.

  • How many employees does Cofactor Genomics have?

    Cofactor Genomics has 18 employees.

  • Who are Cofactor Genomics competitors?

    Competitors of Cofactor Genomics include Phenomenex, The Biomedical Engineering Society and Althea.

  • Where is Cofactor Genomics headquarters?

    Cofactor Genomics headquarters is located at 600 California St, San Francisco, San Francisco.

  • Where are Cofactor Genomics offices?

    Cofactor Genomics has offices in San Francisco and St. Louis.

  • How many offices does Cofactor Genomics have?

    Cofactor Genomics has 2 offices.